category,datetime,headline,id,image,related,source,summary,url
company,1769209202,Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider,138230607,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,"In the closing of the recent trading day, Boston Scientific (BSX) stood at $92.51, denoting a +1.34% move from the preceding trading day.",https://finnhub.io/api/news?id=7873a7b7827179a0bb574873aca50df6642f051b9078ac46793a8073bf00425f
company,1769186580,"ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines",138228529,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,Intuitive Surgical stock gains after Q4 EPS and revenue top estimates as system placements and procedure growth offset a decline in gross margin.,https://finnhub.io/api/news?id=0bd94756fcb44752bf06c4aae8f510c0a5e593f1daae71925ea5fec94614da41
company,1769186220,Boston Scientific Corp. stock outperforms competitors on strong trading day,138285499,,BSX,MarketWatch,Boston Scientific Corp. stock outperforms competitors on strong trading day,https://finnhub.io/api/news?id=3633fc3cdc7f2eaf606859c16a178ff2a89d1467b3e6ff5a160df354a7319319
company,1769142838,1 of Wall Street’s Favorite Stock with Promising Prospects and 2 We Find Risky,138229402,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,"Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.",https://finnhub.io/api/news?id=aca3c6e720f643e6f8294fd6b2198d20d51dfd4e1829bbf6b697ce8774b8f6b4
company,1769136778,Oppenheimer Questions $14.5B Penumbra Deal Valuation Despite Boston Scientific’s (BSX) Mew Market Dominance,138220893,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BSX,Yahoo,"Boston Scientific Corporation (NYSE:BSX) is one of the best mid-cap growth stocks to buy right now. On January 16, Oppenheimer lowered its price target on Boston Scientific to $100 from $125 with an Outperform rating. Oppenheimer is cautious on the financial optics of Boston Scientific’s $14.5 billion acquisition of Penumbra. Although the deal creates a […]",https://finnhub.io/api/news?id=797b355c88d860e8fab0e814e4ed7a3c278b53653f3e5d313b4ebef4292040ab
